Daily as of 3 Nov 16:00 ET
- Price
- above both $167.47 vs 50 $151.77 / 200 $140.34
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 27 Aug 2026 · projected 16 bars out
GILD | Gilead SciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$167.47
-$2.86 (-1.68%)
Gilead Sciences (GILD) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2017.
The 50 SMA has sat above the 200 on the daily since Aug 2026, with no cross projected inside the 30 bars Cruxta tracks. Price sits above the 50 and the 200 on the daily, the weekly and the 4-hour.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $170.68 vs 50 $137.28 / 200 $100.31
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 9 Jan 2023 · projected 13 bars out
4-hour as of 3 Nov 13:30 ET
- Price
- above both $169.66 vs 50 $154.39 / 200 $141.73
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross 13 Aug 2026 · projected 12 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 27 Aug 2026 | 🟨Golden moderate | daily | 16 bars out | Not tested |
| 13 Aug 2026 | 🟨Golden | 4-hour | 12 bars out | Not tested |
| 1 Jul 2026 | 💀Death moderate | daily | 29 bars out | 4 bar cross test |
| 1 May 2026 | 💀Death | 4-hour | 30 bars out | 3 bar cross test |
| 6 Jun 2025 | 🟨Golden | 4-hour | 21 bars out | — |
About GILD
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$802M
4-hour coverageYes, since Oct 2025
History on recordSince 2017
SectorHealthcare
Cap bandlarge